Dynavax Technologies



Ebitda Changement Date
AbbVie USD 4.4B 2.52B 2025-03
Adma Biologics USD 40.41M 1.17M 2024-12
Amgen USD 3.6B 147M 2025-06
AstraZeneca USD 4.96B 127M 2025-06
Biogen USD 1.01B 456.5M 2025-06
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Bristol-Myers Squibb USD 3.27B 1.63B 2025-06
Dynavax Technologies USD -21594000 22.03M 2025-03
Gilead Sciences USD 3.4B 797M 2025-06
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Merck USD 7.74B 625M 2025-03
Neurocrine Biosciences USD 152.9M 121.6M 2025-06
Novartis USD 6.17B 339M 2025-06
Pfizer USD 5.32B 889M 2025-06
Regeneron Pharmaceuticals USD 1.66B 926.5M 2025-06
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
TG Therapeutics USD 12.28M 17.68M 2025-03
Vertex Pharmaceuticals USD 1.34B 556.6M 2025-06


Dynavax Technologies - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.